Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures. Issue 3 (December 2016)
- Record Type:
- Journal Article
- Title:
- Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures. Issue 3 (December 2016)
- Main Title:
- Comparison of Spectra Optia and COBE Spectra apheresis systems' performances for red blood cell exchange procedures
- Authors:
- Kim, Jaehyup
Joseph, Ranjit
Matevosyan, Karen
Sarode, Ravi - Abstract:
- Abstract: Background: Spectra Optia (Terumo BCT, Lakewood, CO) was FDA approved for red blood cell exchange (RBCx) procedures in January 2014 and is expected to replace COBE spectra (Terumo BCT) very soon in the USA. The performance characteristics of these devices for Isovolemic Hemodilution (IHD-RBCx) procedure were compared in this study. Methods: A total of 114 IHD-RBCx procedures from 19 patients were analyzed. For every patient, three procedures on each device with similar pre-procedure hematocrits were compared. Pre and post procedure laboratory parameters compared were hemoglobin S (HbS), hematocrits (Hct), platelet counts and fraction of cells remaining (FCR). Statistical analysis was performed using t-test adjusted by the Holm-Bonferroni method to reduce family-wise error rate. Results: There were no significant differences between these two devices in regards to HbS, Hct, FCR and platelet counts (p = > 0.05). However, rinseback volume (124.2 ± 8.9 ml) and normal saline replacement volume during IHD phase (296.1 ± 97.2 ml) were lower in Spectra Optia as compared to COBE Spectra (337 ± 33.8 ml and 326.6 ± 105.2 ml, p value <0.001 and 0.030 respectively). Spectra Optia had a longer run time (107.1 ± 15.9 min vs 123.8 ± 19.6 min, p value <0.001) overall. Conclusions: Performance characteristics of Spectra Optia for HbS, Hct and FCR were similar to COBE Spectra for IHD-RBCx. IHD-RBCx procedure on Optia required less normal saline replacement volume and rinse backAbstract: Background: Spectra Optia (Terumo BCT, Lakewood, CO) was FDA approved for red blood cell exchange (RBCx) procedures in January 2014 and is expected to replace COBE spectra (Terumo BCT) very soon in the USA. The performance characteristics of these devices for Isovolemic Hemodilution (IHD-RBCx) procedure were compared in this study. Methods: A total of 114 IHD-RBCx procedures from 19 patients were analyzed. For every patient, three procedures on each device with similar pre-procedure hematocrits were compared. Pre and post procedure laboratory parameters compared were hemoglobin S (HbS), hematocrits (Hct), platelet counts and fraction of cells remaining (FCR). Statistical analysis was performed using t-test adjusted by the Holm-Bonferroni method to reduce family-wise error rate. Results: There were no significant differences between these two devices in regards to HbS, Hct, FCR and platelet counts (p = > 0.05). However, rinseback volume (124.2 ± 8.9 ml) and normal saline replacement volume during IHD phase (296.1 ± 97.2 ml) were lower in Spectra Optia as compared to COBE Spectra (337 ± 33.8 ml and 326.6 ± 105.2 ml, p value <0.001 and 0.030 respectively). Spectra Optia had a longer run time (107.1 ± 15.9 min vs 123.8 ± 19.6 min, p value <0.001) overall. Conclusions: Performance characteristics of Spectra Optia for HbS, Hct and FCR were similar to COBE Spectra for IHD-RBCx. IHD-RBCx procedure on Optia required less normal saline replacement volume and rinse back volume but with overall longer procedure run time. … (more)
- Is Part Of:
- Transfusion and apheresis science. Volume 55:Issue 3(2016)
- Journal:
- Transfusion and apheresis science
- Issue:
- Volume 55:Issue 3(2016)
- Issue Display:
- Volume 55, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 55
- Issue:
- 3
- Issue Sort Value:
- 2016-0055-0003-0000
- Page Start:
- 368
- Page End:
- 370
- Publication Date:
- 2016-12
- Subjects:
- Sickle cell anemia -- Red blood cell exchange -- COBE Spectra -- Spectra Optia
Blood -- Transfusion -- Periodicals
Hemapheresis -- Periodicals
615.39 - Journal URLs:
- http://www.sciencedirect.com/science/journal/14730502 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/14730502 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/14730502 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.transci.2016.10.004 ↗
- Languages:
- English
- ISSNs:
- 1473-0502
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9020.704500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2672.xml